AGENUS INC Intellectual Property Contracts & Agreements
20 Contracts & Agreements
- License Agreements (20 contracts)
- License, Development and Commercialization Agreement, dated May 17, 2021, by and between Agenus Inc. and Bristol Myers Squibb Company (Filed With SEC on August 9, 2021)
- Option and License Agreement (AGEN2373) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
- Option and License Agreement (AGEN1223) dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
- License Agreement dated December 20, 2018, by and between Agenus Inc. and Gilead Sciences, Inc (Filed With SEC on March 18, 2019)
- FIRST AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 4, 2017)
- LICENSE AGREEMENT (Filed With SEC on March 15, 2016)
- license agreement University of Virginia Licensing & Ventures Group PhosImmune, Inc. (Filed With SEC on March 15, 2016)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN AGENUS INC., 4-ANTIBODY AG, INCYTE EUROPE SARL, AND INCYTE CORPORATION, SOLELY FOR PURPOSES OF SECTION 12.16 (Filed With SEC on March 16, 2015)
- LICENSE AGREEMENT (Filed With SEC on March 16, 2015)
- LICENSE AND DEVELOPMENT AND MANUFACTURING TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on March 6, 2012)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on November 9, 2009)
- AMENDMENT NUMBER TWO LICENSE AGREEMENT (Filed With SEC on August 10, 2009)
- AMENDMENT NO. 8 TO THE PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on August 8, 2008)
- EXCLUSIVE LICENSE AGREEMENT Table of Contents (Filed With SEC on May 9, 2008)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 9, 2008)
- AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on March 17, 2008)
- Amendment No. 1 to the Exclusive License Agreement of July 1, 1988 (Filed With SEC on March 17, 2008)
- LICENSE AGREEMENT (Filed With SEC on November 14, 2007)
- LICENSE AGREEMENT BY AND BETWEEN ANTIGENICS, INC., A MASSACHUSETTS CORPORATION AND GLAXOSMITHKLINE BIOLOGICALSSA (Filed With SEC on August 9, 2006)
- EX-10.2 LICENSE AGREEMENT DATED 5/25/01 (Filed With SEC on May 15, 2003)
